Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nicotinic cholinergic system and COVID-19: In silico evaluation of nicotinic acetylcholine receptor agonists as potential therapeutic interventions
Nikolaos Alexandris, George Lagoumintzis, Christos T. Chasapis, et al.
Toxicology Reports (2020) Vol. 8, pp. 73-83
Open Access | Times Cited: 60

Showing 1-25 of 60 citing articles:

COVID-19 pandemic and alcohol consumption: Impacts and interconnections
Daniela Călina, Thomas Härtung, Ileana Mardare, et al.
Toxicology Reports (2021) Vol. 8, pp. 529-535
Open Access | Times Cited: 145
Safety of COVID-19 vaccines administered in the EU: Should we be concerned?
Antonio F. Hernández, Daniela Călina, Konstantinos Poulas, et al.
Toxicology Reports (2021) Vol. 8, pp. 871-879
Open Access | Times Cited: 136
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
Peter Parry, Astrid Lefringhausen, Conny Turni, et al.
Biomedicines (2023) Vol. 11, Iss. 8, pp. 2287-2287
Open Access | Times Cited: 53
Covid-19-Induced Dysautonomia: A Menace of Sympathetic Storm
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Safaa Qusti, et al.
ASN NEURO (2021) Vol. 13, pp. 175909142110576-175909142110576
Open Access | Times Cited: 79
Effects of β-Blockers on the Sympathetic and Cytokines Storms in Covid-19
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Gomaa Mostafa‐Hedeab, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 56
RETRACTED: Use of ivermectin in the treatment of Covid-19: A pilot trial
Henrique Pott, Mônica Maria Bastos Paoliello, Alice de Queiroz Constantino Miguel, et al.
Toxicology Reports (2021) Vol. 8, pp. 505-510
Open Access | Times Cited: 43
Ginkgo Biloba and Long COVID: In Vivo and In Vitro Models for the Evaluation of Nanotherapeutic Efficacy
Thelma Akanchise, Angelina Angelova
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1562-1562
Open Access | Times Cited: 17
Cholinergic dysfunction in COVID-19: frantic search and hoping for the best
Eman Hassan Nadwa, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 396, Iss. 3, pp. 453-468
Open Access | Times Cited: 28
The role of HMGB1 in COVID‐19‐induced cytokine storm and its potential therapeutic targets: A review
Sri Wulandari, Hartono Hartono, Tri Wibawa
Immunology (2022) Vol. 169, Iss. 2, pp. 117-131
Open Access | Times Cited: 20
Is the post-COVID-19 syndrome a severe impairment of acetylcholine-orchestrated neuromodulation that responds to nicotine administration?
Marco Leitzke
Bioelectronic Medicine (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 12
Spike protein-related proteinopathies: a focus on the neurological side of spikeopathies
Andreas Posa
Annals of Anatomy - Anatomischer Anzeiger (2025), pp. 152662-152662
Open Access
COVID-19 and Alzheimer’s Disease Share Common Neurological and Ophthalmological Manifestations: A Bidirectional Risk in the Post-Pandemic Future
Giuseppina Amadoro, Valentina Latina, Egidio Stigliano, et al.
Cells (2023) Vol. 12, Iss. 22, pp. 2601-2601
Open Access | Times Cited: 10
Immune response (IgG) following full inoculation with BNT162b2 COVID‑19 mRNA among healthcare professionals
Aristidis Tsatsakis, Elena Vakonaki, Manolis Tzatzarakis, et al.
International Journal of Molecular Medicine (2021) Vol. 48, Iss. 5
Open Access | Times Cited: 21
Citicoline and COVID-19: vis-à-vis conjectured
Hayder M. Al‐kuraishy, Ali K. Albuhadily, Ali I. Al‐Gareeb, et al.
Naunyn-Schmiedeberg s Archives of Pharmacology (2022) Vol. 395, Iss. 12, pp. 1463-1475
Open Access | Times Cited: 15
Discovery of a new long COVID mouse model via systemic histopathological comparison of SARS-CoV-2 intranasal and inhalation infection
Donghun Jeon, Sunghee Kim, Jiseon Kim, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2024) Vol. 1870, Iss. 7, pp. 167347-167347
Open Access | Times Cited: 3
Nicotinic receptors as SARS-CoV-2 spike co-receptors?
Valérian Dormoy, Jeanne‐Marie Perotin, Philippe Gosset, et al.
Medical Hypotheses (2021) Vol. 158, pp. 110741-110741
Open Access | Times Cited: 19
Smoking Status, Nicotine Medication, Vaccination, and COVID-19 Hospital Outcomes: Findings from the COVID EHR Cohort at the University of Wisconsin (CEC-UW) Study
Thomas M. Piasecki, Stevens S. Smith, Timothy B. Baker, et al.
Nicotine & Tobacco Research (2022) Vol. 25, Iss. 6, pp. 1184-1193
Open Access | Times Cited: 13
Is SARS-CoV-2 Spike glycoprotein impairing macrophage function via α7-nicotinic acetylcholine receptors?
Tanmay Saraiya, Dimitris Labrou, Konstantinos Farsalinos, et al.
Food and Chemical Toxicology (2021) Vol. 152, pp. 112184-112184
Open Access | Times Cited: 15
Tobacco smoking and severity of COVID‐19: Experience from a hospital‐based prospective cohort study in Lyon, France
Mitra Saadatian‐Elahi, S. Amour, Christelle Elias, et al.
Journal of Medical Virology (2021) Vol. 93, Iss. 12, pp. 6822-6827
Open Access | Times Cited: 15
Central Effects of Ivermectin in Alleviation of Covid-19-induced Dysauto-nomia
Αθανάσιος Αλεξίου, Gaber El‐Saber Batiha, Hayder M. Al‐kuraishy, et al.
Current Drug Targets (2022) Vol. 23, Iss. 13, pp. 1277-1287
Closed Access | Times Cited: 10
Identification of methylation signatures and rules for predicting the severity of SARS-CoV-2 infection with machine learning methods
Zhiyang Liu, Mei Meng, Shi‐Jian Ding, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 9
An experimental test of the nicotinic hypothesis of COVID-19
Nicole E. Godellas, Gisela D. Cymes, Claudio Grosman
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 44
Open Access | Times Cited: 8
Nicotine exposure decreases likelihood of SARS-CoV-2 RNA expression and neuropathology in the hACE2 mouse brain but not moribundity
Ayland C. Letsinger, James M. Ward, Rick D. Fannin, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 4
Regulation of Inflammation by IRAK-M Pathway Can Be Associated with nAchRalpha7 Activation and COVID-19
Alessanda S. Rieder, Angela T. S. Wyse
Molecular Neurobiology (2023) Vol. 61, Iss. 2, pp. 581-592
Closed Access | Times Cited: 4
Nornicotine‐Typed Insecticides: The Potential Insecticides with Strong Activity Against Aedes Albopictus
Fangfei Cao, Ying Deng, Yanxin Zhang, et al.
ChemistrySelect (2024) Vol. 9, Iss. 13
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top